Priority Date: 03.08.12 (KR 20120085436)

NOVEL MONOCLONAL ANTIBODY WHICH IS SPECIFICALLY BOUND TO TM4SF5 PROTEIN AND USE THEREOF

  • Application ID: EP13824875
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 11 - 50 employees
Company dna sonn and partner
no operation time available
Headquarter in Vienna
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service

Specialization

This patent has the IPC combination A61, C07, and G01 Sonn & Partner is specialized in the combination A61, C07, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP, Vereenigde Octrooibureaux NV (V.O.) and 56 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 03.08.2012 - Priority Date (KR 20120085436)
  • 06.02.2014 - Publication A2 (WO2014021693)
  • 24.06.2015 - Publication A2 (EP2886556)